Skip to content
Medical Health Aged Care, Mental Health

Help your brain filter out tinnitus and get your life back this Tinnitus Awareness Week

MindEar 2 mins read

Experts available to talk about tinnitus, their family experience, and how new tools can make a difference for millions of people - in Sydney, Australia, and in Bristol and Newcastle (UK)

A free trial of the latest evidence-based therapies is available for Tinnitus Awareness Week.

The seven-day challenge incorporates the latest research from Newcastle University in the UK along with research from Auckland University, the Ear Institute at University College London and Leeds Trinity University.

  • Many people living with tinnitus are still told that “nothing can be done” but clinicians following the latest research say that is bad advice which can lead to more stress, anxiety, and depression.
  • While there is no cure, there are new evidence-based tools that help reduce the impact of tinnitus. You can help your brain filter out the noise and get your life back.
  • These approaches are available for free trial during Tinnitus Awareness Week via a guided 7-day challenge.
  • The free Sound Wellness Challenge is available online at:
    tools.mindear.com/sound-wellness-challenge

Our researchers are available for interview about the trial and about the broader issues of tinnitus including:

  • What tinnitus is (and what it isn’t), including why the brain can lock on to the sound
  • What actually helps (and what doesn’t), and why advice to “just ignore it” often backfires
  • The role of Cognitive Behavioural Therapy (CBT) based approaches, and why access has traditionally been a bottleneck
  • Digital care and apps: what the evidence suggests, who it might suit, and how to use them safely as part of a broader care plan
  • The guided 7-day challenge giving access to the latest evidence-based sound tools, and the research that informs the tools.
  • How to spot red flags and avoid miracle cures that exploit desperation.

They can also speak to their personal experience of tinnitus in their own families, and how those experiences led them to dedicate their professional lives looking for better options. 

General background on tinnitus is also attached to support your coverage.


Contact details:
  • Dr Matthieu Recugnat (Sydney, Australia), whose grandmother suffered severely from tinnitus. [email protected] +61 432 064 071
  • Dr Fabrice Bardy (UK, Bristol), whose father developed severe tinnitus after a head injury. [email protected] +44 7878 140 422; +33 744 81 82 88
  • Dr Will Sedley (UK, Newcastle) Researcher who has been leading the development of the new soundscapes for tinnitus [email protected] +44 7713 632553
  • For general interviews or background, contact Fabrice or Matthieu directly. Will can speak directly to the Newcastle research and how it has been adopted in the 7-day challenge
  • For media coordination: Niall Byrne: [email protected], +61 417 131 977.

Media

More from this category

  • Medical Health Aged Care
  • 31/01/2026
  • 00:10
Kyowa Kirin

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Kyowa Kirin affirms commitment to developing rocatinlimab as a life-changing differentiated asset with significant market potential.Rocatinlimab’s novel approach as an investigational T-cell rebalancing therapy directly targeting the OX40 receptor expressed on pathogenic T-cells shows potential to deliver long-term disease control in patients with moderate-to-severe atopic dermatitis (msAD).Regulatory submission is planned in the first half of 2026.TOKYO and PRINCETON, N.J., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin Co., Ltd. (TSE:4151, Kyowa Kirin), a Japan-based global specialty pharmaceutical company, today announced the termination of the current rocatinlimab development and commercialization collaboration with Amgen. Kyowa Kirin will regain control of the global…

  • Medical Health Aged Care
  • 30/01/2026
  • 17:12
Galderma

Galderma Tackles Menopause-related Skin Changes With Global Survey and Clinical Trial Inclusivity

Results from a global survey of over 4,300 women across five continents presented at IMCAS 2026 reveal a knowledge gap on the impact of…

  • Contains:
  • Medical Health Aged Care
  • 30/01/2026
  • 15:03
Dementia Australia

Get active for your brain health and beat dementia in Cronulla!

The 2026 Cronulla Memory Walk & Jog is just weeks away, with the event taking place on Sunday 1 March at Don Lucas Reserve, Cronulla. As Dementia Australia’s largest annual fundraising initiative, Memory Walk & Jog brings communities together to get active, get connected and support Australians living with dementia, their families and carers. More than 141,800 people are living with dementia in New South Wales. Dementia is now the leading cause of death for Australians, and without significant intervention, the number of Australians living with dementia is expected to increase to more than one million by 2065. In 2026,…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.